PL1848731T3 - Antybiotyk 107891, jego czynniki, farmaceutycznie dopuszczalne sole i kompozycje oraz ich zastosowanie - Google Patents

Antybiotyk 107891, jego czynniki, farmaceutycznie dopuszczalne sole i kompozycje oraz ich zastosowanie

Info

Publication number: PL1848731T3
Authority: PL; Poland
Prior art keywords: antibiotic; factors; compositions; pharmaceutically acceptable; acceptable salts
Prior art date: 2005-01-26

Application number

PL05712250T

Other languages

English (en)

Inventor

Ameriga Lazzarini

Luciano Gastaldo

Gianpaolo Candiani

Ismaela Ciciliato

Daniele Losi

Flavia Marinelli

Enrico Selva

Franco Parenti

Original Assignee

Sentinella Pharmaceuticals Inc Sentinella

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-01-26

Filing date

2005-01-27

Publication date

2012-10-31

2005-01-27 Application filed by Sentinella Pharmaceuticals Inc Sentinella filed Critical Sentinella Pharmaceuticals Inc Sentinella

2012-10-31 Publication of PL1848731T3 publication Critical patent/PL1848731T3/pl

Links

230000003115 biocidal effect Effects 0.000 title 1
239000000203 mixture Substances 0.000 title 1
150000003839 salts Chemical class 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Biophysics (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Biotechnology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Engineering & Computer Science (AREA)
Microbiology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Tropical Medicine & Parasitology (AREA)
Epidemiology (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Nutrition Science (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

PL05712250T 2005-01-26 2005-01-27 Antybiotyk 107891, jego czynniki, farmaceutycznie dopuszczalne sole i kompozycje oraz ich zastosowanie PL1848731T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US11/045,628 US7351687B2 (en)	2003-07-18	2005-01-26	Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof
EP05712250A EP1848731B1 (en)	2005-01-26	2005-01-27	Antibiotic 107891, its factors, pharmaceutically acceptable salts and compositions, and use thereof
PCT/US2005/002733 WO2006080920A1 (en)	2005-01-26	2005-01-27	Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof

Publications (1)

Publication Number	Publication Date
PL1848731T3 true PL1848731T3 (pl)	2012-10-31

Family

ID=36740829

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL05712250T PL1848731T3 (pl)	2005-01-26	2005-01-27	Antybiotyk 107891, jego czynniki, farmaceutycznie dopuszczalne sole i kompozycje oraz ich zastosowanie

Country Status (26)

Country	Link
US (1)	US7351687B2 (pl)
EP (2)	EP2402366A1 (pl)
JP (1)	JP4191238B2 (pl)
KR (1)	KR100896826B1 (pl)
CN (1)	CN101189252B (pl)
AU (1)	AU2005326149C1 (pl)
BR (1)	BRPI0519942A2 (pl)
CA (1)	CA2593801A1 (pl)
CY (1)	CY1113030T1 (pl)
DK (1)	DK1848731T3 (pl)
EA (1)	EA016608B1 (pl)
ES (1)	ES2387557T3 (pl)
HR (1)	HRP20120634T1 (pl)
IL (1)	IL184377A0 (pl)
MA (1)	MA29237B1 (pl)
MX (1)	MX2007009059A (pl)
NO (1)	NO20073490L (pl)
NZ (1)	NZ556368A (pl)
PL (1)	PL1848731T3 (pl)
PT (1)	PT1848731E (pl)
RS (1)	RS52427B (pl)
SI (1)	SI1848731T1 (pl)
TN (1)	TNSN07286A1 (pl)
UA (1)	UA87548C2 (pl)
WO (1)	WO2006080920A1 (pl)
ZA (1)	ZA200705495B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0600928D0 (en)	2006-01-17	2006-02-22	Novacta Biosystems Ltd	Improvements relating to lantibiotics
GB0714030D0 (en)	2007-07-18	2007-08-29	Novacta Biosystems Ltd	The use of type-B lantibiotic-based compounds having antimicrobial activity
GB0714029D0 (en)	2007-07-18	2007-08-29	Novacta Biosystems Ltd	Lantibiotic-based compounds having antimicrobial activity
SI2387580T1 (sl)	2009-01-14	2014-11-28	Novacta Biosystems Limited	Deoksiaktagardinski derivati
NZ594675A (en)	2009-02-04	2013-11-29	Novacta Biosystems Ltd	Actagardine derivatives
GB201001688D0 (en)	2010-02-02	2010-03-17	Novacta Biosystems Ltd	Compounds
GB201013513D0 (en)	2010-08-11	2010-09-22	Novacta Biosystems Ltd	Formulations
US11174288B2 (en)	2016-12-06	2021-11-16	Northeastern University	Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS59198982A (ja)	1983-04-28	1984-11-10	Meiji Seika Kaisha Ltd	新抗生物質ｓｆ−２２４０物質およびその製造法
EP0592835A3 (en)	1992-09-23	1995-03-15	Bristol Myers Squibb Co	Antibiotics of type BU-4803T.
US6551591B1 (en)	2001-09-07	2003-04-22	Essential Therapeutics, Inc.	Antibiotics from microbispora
US6551581B1 (en)	2001-12-27	2003-04-22	Avon Products, Inc.	Methods for improving the aesthetic appearance of skin and hair
BRPI0412591A (pt) *	2003-07-18	2006-09-19	Vicuron Pharm Inc	antibiótico 107891, seus fatores a1 e a2, sais e composições farmaceuticamente aceitáveis e uso destes
PT1855705E (pt) *	2005-01-12	2012-10-16	Sentinella Pharmaceuticals Inc Sentinella	Antibiótico 107891, seus factores, seus sais aceitáveis sob o ponto de vista farmacêutico e suas composições, e sua utilização
BRPI0519325A2 (pt) *	2005-01-12	2009-01-13	Vicuron Pharm Inc	compostos, complexo antibiàtico 107891, seus fatores a1 e a2, sais farmaceuticamente aceitÁveis, processo para produzir composiÇço e uso do mesmo
WO2006075988A1 (en) *	2005-01-12	2006-07-20	Vicuron Pharmaceuticals Inc.	Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof

2005
- 2005-01-26 US US11/045,628 patent/US7351687B2/en not_active Expired - Lifetime
- 2005-01-27 RS RS20120359A patent/RS52427B/en unknown
- 2005-01-27 NZ NZ556368A patent/NZ556368A/en not_active IP Right Cessation
- 2005-01-27 EA EA200701384A patent/EA016608B1/ru not_active IP Right Cessation
- 2005-01-27 DK DK05712250.9T patent/DK1848731T3/da active
- 2005-01-27 JP JP2007553072A patent/JP4191238B2/ja not_active Expired - Fee Related
- 2005-01-27 WO PCT/US2005/002733 patent/WO2006080920A1/en active Application Filing
- 2005-01-27 PT PT05712250T patent/PT1848731E/pt unknown
- 2005-01-27 AU AU2005326149A patent/AU2005326149C1/en not_active Ceased
- 2005-01-27 BR BRPI0519942-5A patent/BRPI0519942A2/pt not_active IP Right Cessation
- 2005-01-27 CN CN2005800472656A patent/CN101189252B/zh not_active Expired - Fee Related
- 2005-01-27 MX MX2007009059A patent/MX2007009059A/es active IP Right Grant
- 2005-01-27 EP EP11001502A patent/EP2402366A1/en not_active Withdrawn
- 2005-01-27 KR KR1020077017177A patent/KR100896826B1/ko not_active IP Right Cessation
- 2005-01-27 PL PL05712250T patent/PL1848731T3/pl unknown
- 2005-01-27 ES ES05712250T patent/ES2387557T3/es active Active
- 2005-01-27 UA UAA200708557A patent/UA87548C2/ru unknown
- 2005-01-27 SI SI200531553T patent/SI1848731T1/sl unknown
- 2005-01-27 EP EP05712250A patent/EP1848731B1/en active Active
- 2005-01-27 CA CA002593801A patent/CA2593801A1/en not_active Abandoned
2007
- 2007-07-03 IL IL184377A patent/IL184377A0/en unknown
- 2007-07-05 ZA ZA200705495A patent/ZA200705495B/xx unknown
- 2007-07-05 NO NO20073490A patent/NO20073490L/no not_active Application Discontinuation
- 2007-07-24 TN TNP2007000286A patent/TNSN07286A1/fr unknown
- 2007-07-26 MA MA30106A patent/MA29237B1/fr unknown
2012
- 2012-08-02 HR HRP20120634TT patent/HRP20120634T1/hr unknown
- 2012-08-13 CY CY20121100727T patent/CY1113030T1/el unknown

Also Published As

Publication number	Publication date
JP2008528581A (ja)	2008-07-31
HRP20120634T1 (hr)	2012-08-31
MA29237B1 (fr)	2008-02-01
CA2593801A1 (en)	2006-08-03
US7351687B2 (en)	2008-04-01
PT1848731E (pt)	2012-08-20
EA016608B1 (ru)	2012-06-29
EP1848731A4 (en)	2008-11-12
NZ556368A (en)	2010-09-30
CN101189252B (zh)	2012-07-18
UA87548C2 (ru)	2009-07-27
CY1113030T1 (el)	2016-04-13
SI1848731T1 (sl)	2012-09-28
AU2005326149A1 (en)	2006-08-03
EP1848731A1 (en)	2007-10-31
DK1848731T3 (da)	2012-09-03
CN101189252A (zh)	2008-05-28
US20050233952A1 (en)	2005-10-20
KR20070090043A (ko)	2007-09-04
WO2006080920A1 (en)	2006-08-03
RS52427B (en)	2013-02-28
JP4191238B2 (ja)	2008-12-03
EP2402366A1 (en)	2012-01-04
MX2007009059A (es)	2008-02-12
KR100896826B1 (ko)	2009-05-12
NO20073490L (no)	2007-08-07
ZA200705495B (en)	2008-12-31
ES2387557T3 (es)	2012-09-26
BRPI0519942A2 (pt)	2009-04-07
AU2005326149B2 (en)	2009-10-29
IL184377A0 (en)	2007-10-31
AU2005326149C1 (en)	2010-04-01
TNSN07286A1 (fr)	2008-12-31
EA200701384A1 (ru)	2008-02-28
EP1848731B1 (en)	2012-05-23

Publication	Publication Date	Title
IL175953A (en)	2015-09-24	Derivatives of 3-Cycloalkylaminopyrrolidine, their Pharmaceutical Salts and Preparations Containing Them
IL192298A (en)	2016-02-29	Heterocyclic Compounds, Their Acceptable Salts, Pharmaceuticals Containing and Using Them
IL184901A0 (en)	2007-12-03	2,4-diamino-pyridopyrimidine derivatives and their use as mtor inhibitors
IL178079A (en)	2015-04-30	History of phenyl 1-phenyl-4,3,2,1-tetrahydro-beta-carboline-2-carboxylate and medicinal preparations containing them
IL189781A0 (en)	2008-08-07	Sulphonylpyrrole hydrochloride salts and pharmaceutical compositions containing the same
ZA200709856B (en)	2009-12-30	Fluorene derivatives,compositions containing said derivatives and the use thereof
EP1890677A4 (en)	2013-01-30	PHARMACEUTICAL COMPOSITIONS AND THEIR USE
AU2006321904A8 (en)	2008-07-17	1, 1, 3-trioxo-1 , 2 , 5-thiadiazolidines and their use as PTP-ases inhibitors
ZA200705495B (en)	2008-12-31	Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof
EP1916251A4 (en)	2010-09-08	ERIANINE SALTS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
ZA200706672B (en)	2008-10-29	2,4-Diamino-pyridopyrimidine derivatives and their use as mTOR inhibitors
PL394604A1 (pl)	2011-07-18	Pochodna winyloazacykloalkanowa, jej zastosowanie oraz kompozycja farmaceutyczna
TWI340167B (en)	2011-04-11	Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof
GB2452696B (en)	2009-09-23	3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions
IL181216A0 (en)	2007-07-04	3, 5-seco-4-norcholestane derivatives and pharmaceutical compositions containing the same
IL186337A0 (en)	2008-01-20	Stannsoporfin compositions and administration
HK1098059A1 (en)	2007-07-13	Composition comprising itraconazole for oral administration
IL184376A0 (en)	2007-10-31	Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof
PL1791872T3 (pl)	2009-06-30	Biotynylowane heksadekasacharydy, kompozycje farmaceutyczne i ich zastosowanie
EP1865777A4 (en)	2008-07-16	STANNSOPORFIN COMPOSITIONS AND ADMINISTRATION
ZA200705494B (en)	2008-11-26	Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof
IL191560A0 (en)	2008-12-29	3,4-dihydrobenzoxazine derivatives and pharmaceutical compositions containing the same
GB2444005B (en)	2010-04-07	Compound, composition and use
IL195148A0 (en)	2009-09-22	2-alkoxy-3,4,5-trihydroxy-alkylamide-benzazepines, the preparation and use thereof and compositions containing the same
ZA200810629B (en)	2010-02-24	Phenylpentadienoyl derivatives and their use as par 1 antagonists